These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37278738)

  • 1. Added Value of Internal Fragments for Top-Down Mass Spectrometry of Intact Monoclonal Antibodies and Antibody-Drug Conjugates.
    Wei B; Lantz C; Liu W; Viner R; Ogorzalek Loo RR; Campuzano IDG; Loo JA
    Anal Chem; 2023 Jun; 95(24):9347-9356. PubMed ID: 37278738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal Fragments Enhance Middle-Down Mass Spectrometry Structural Characterization of Monoclonal Antibodies and Antibody-Drug Conjugates.
    Wei B; Lantz C; Ogorzalek Loo RR; Campuzano IDG; Loo JA
    Anal Chem; 2024 Feb; 96(6):2491-2499. PubMed ID: 38294207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Top-down mass spectrometry and assigning internal fragments for determining disulfide bond positions in proteins.
    Wei B; Zenaidee MA; Lantz C; Williams BJ; Totten S; Ogorzalek Loo RR; Loo JA
    Analyst; 2022 Dec; 148(1):26-37. PubMed ID: 36399030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Study to Identify the Drug Conjugation Site of a Site-Specific Antibody-Drug-Conjugate Using Middle-Down Mass Spectrometry.
    Hernandez-Alba O; Houel S; Hessmann S; Erb S; Rabuka D; Huguet R; Josephs J; Beck A; Drake PM; Cianférani S
    J Am Soc Mass Spectrom; 2019 Nov; 30(11):2419-2429. PubMed ID: 31429052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interlaboratory Study for Characterizing Monoclonal Antibodies by Top-Down and Middle-Down Mass Spectrometry.
    Srzentić K; Fornelli L; Tsybin YO; Loo JA; Seckler H; Agar JN; Anderson LC; Bai DL; Beck A; Brodbelt JS; van der Burgt YEM; Chamot-Rooke J; Chatterjee S; Chen Y; Clarke DJ; Danis PO; Diedrich JK; D'Ippolito RA; Dupré M; Gasilova N; Ge Y; Goo YA; Goodlett DR; Greer S; Haselmann KF; He L; Hendrickson CL; Hinkle JD; Holt MV; Hughes S; Hunt DF; Kelleher NL; Kozhinov AN; Lin Z; Malosse C; Marshall AG; Menin L; Millikin RJ; Nagornov KO; Nicolardi S; Paša-Tolić L; Pengelley S; Quebbemann NR; Resemann A; Sandoval W; Sarin R; Schmitt ND; Shabanowitz J; Shaw JB; Shortreed MR; Smith LM; Sobott F; Suckau D; Toby T; Weisbrod CR; Wildburger NC; Yates JR; Yoon SH; Young NL; Zhou M
    J Am Soc Mass Spectrom; 2020 Sep; 31(9):1783-1802. PubMed ID: 32812765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
    Friese OV; Smith JN; Brown PW; Rouse JC
    MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry.
    Zhang Z; Shah B
    Anal Chem; 2007 Aug; 79(15):5723-9. PubMed ID: 17591752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of intact, middle-up and bottom-up levels to characterize 7 therapeutic monoclonal antibodies by capillary electrophoresis - Mass spectrometry.
    Giorgetti J; Beck A; Leize-Wagner E; François YN
    J Pharm Biomed Anal; 2020 Apr; 182():113107. PubMed ID: 32004767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry.
    Pan LY; Salas-Solano O; Valliere-Douglass JF
    Anal Chem; 2014 Mar; 86(5):2657-64. PubMed ID: 24512515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates.
    Botzanowski T; Erb S; Hernandez-Alba O; Ehkirch A; Colas O; Wagner-Rousset E; Rabuka D; Beck A; Drake PM; Cianférani S
    MAbs; 2017 Jul; 9(5):801-811. PubMed ID: 28406343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Top-Down Characterization of an Intact Monoclonal Antibody Using Activated Ion Electron Transfer Dissociation.
    Lodge JM; Schauer KL; Brademan DR; Riley NM; Shishkova E; Westphall MS; Coon JJ
    Anal Chem; 2020 Aug; 92(15):10246-10251. PubMed ID: 32608969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Multi-attribute Analysis of Antibody-Drug Conjugates Enabled by Trapped Ion Mobility Spectrometry and Top-Down Mass Spectrometry.
    Larson EJ; Roberts DS; Melby JA; Buck KM; Zhu Y; Zhou S; Han L; Zhang Q; Ge Y
    Anal Chem; 2021 Jul; 93(29):10013-10021. PubMed ID: 34258999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.
    Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G
    MAbs; 2018; 10(4):583-595. PubMed ID: 29436897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis of an intact monoclonal antibody by online electrochemical reduction of disulfide bonds and Fourier transform ion cyclotron resonance mass spectrometry.
    Nicolardi S; Deelder AM; Palmblad M; van der Burgt YE
    Anal Chem; 2014 Jun; 86(11):5376-82. PubMed ID: 24780057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry.
    Rosati S; Yang Y; Barendregt A; Heck AJ
    Nat Protoc; 2014 Apr; 9(4):967-76. PubMed ID: 24675736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
    Yan Y; Xing T; Wang S; Daly TJ; Li N
    J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native-MS Analysis of Monoclonal Antibody Conjugates by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Campuzano IDG; Netirojjanakul C; Nshanian M; Lippens JL; Kilgour DPA; Van Orden S; Loo JA
    Anal Chem; 2018 Jan; 90(1):745-751. PubMed ID: 29193956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internal Fragments Generated from Different Top-Down Mass Spectrometry Fragmentation Methods Extend Protein Sequence Coverage.
    Zenaidee MA; Wei B; Lantz C; Wu HT; Lambeth TR; Diedrich JK; Ogorzalek Loo RR; Julian RR; Loo JA
    J Am Soc Mass Spectrom; 2021 Jul; 32(7):1752-1758. PubMed ID: 34101447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary middle-down and intact monoclonal antibody proteoform characterization by capillary zone electrophoresis - mass spectrometry.
    Belov AM; Zang L; Sebastiano R; Santos MR; Bush DR; Karger BL; Ivanov AR
    Electrophoresis; 2018 Aug; 39(16):2069-2082. PubMed ID: 29749064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pepsin-Containing Membranes for Controlled Monoclonal Antibody Digestion Prior to Mass Spectrometry Analysis.
    Pang Y; Wang WH; Reid GE; Hunt DF; Bruening ML
    Anal Chem; 2015 Nov; 87(21):10942-9. PubMed ID: 26455365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.